Scientists have developed a super vaccine that can inhibit 70% of deadly cancers

Scientists have developed a vaccine that can fight seven out of ten deadly cancers. Tests have shown that it can reduce breast cancer mass by 80%, and researchers believe it can also prevent prostate cancer, pancreatic cancer, intestinal cancer and ovarian cancer.

Even tumors that cannot be treated with the best drugs such as Herceptin on the market today may be affected by this new vaccine. The vaccine has been tested in mice so far, but the researchers hope to test it in humans within two years. If all goes well, the vaccine (the first vaccine against cancer) will hit the market in 2020. More than 300,000 cancer patients are diagnosed in the UK each year, and about half of them die from such diseases every year.

A new drug helps fight 70% of cancers

Unlike many drugs, this new vaccine does not attack cancer cells, but uses the immune system to fight tumors. So far the most worrying issue in finding a cancer vaccine is to destroy healthy tissues while destroying tumor cells. To prevent this from happening, researchers at the University of Georgia and the Mayo Clinic focused on a protein called MUC1, which is more in cancer cells than in healthy cells. Not only is there more MUC1 for cancer cells, but the sugar used to "decorate" it also has a distinctive shape.

The vaccine "trains" the immune system to recognize this rogue sugar and uses its arsenal to fight cancer. Professor Sandra Gendler said: "Cancer cells have a special way of evading the immune system. The surface of the tumor cells is covered with sugar, so that they can freely swim in the body without being discovered by the immune system. Out of this sugar, it uses a special vaccine composed of three parts. The results prove that this is a very successful combination. "Professor Gert-Jane-Burns, author of the joint thesis, said:" This vaccine caused a lot of Strong immune response. It stimulates the three components of the immune system, shrinking the tumor volume by as much as 80%. "

This deformed MUC1 sugar can be found in 90% of breast and pancreatic cancers, as well as about 60% of prostate cancers and many other tumors. The researchers believe that more than 70% of the tumors killed may be very sensitive to this vaccine. Although they have conducted some experiments, this research is still in its early stages. After the results of experiments conducted on mice with breast cancer yielded "attractive" results, the researchers now intend to use the drug on human cancer cells in test vessels.

Before the vaccine proves to be very safe and effective and can be widely used in hospitals, it will take many years for large-scale human trials. Subsequently, the existing drugs will be used to improve the therapeutic effect and prevent tumor recurrence after surgery. Dr. Burns founded a biotechnology company to commercialize this vaccine, he said: "We started to have a treatment that can teach our immune system to fight cancer cells. Combined with early diagnosis, we hope One day cancer will become a curable disease. "This vaccine is one of several ways to treat cancer by stimulating the immune system to attack and kill cancer cells.

Dr. Caitlyn Palframan, who has broken through breast cancer, said: "This exciting new method will bring new hope for the treatment of breast cancer patients who have no choice. In the future, it also hopes to vaccinate women at high risk Fighting breast cancer offers possibilities. However, before we understand all its potential, we also need to take a look at the effects of this method on cancer patients. "Oliver-Ziders of the British Cancer Institute said:" These researchers are not alone in using the human immune system to fight cancer, because this is an important research area of ​​global interest. This research is very interesting, but there is still a long way to go before applying a vaccine to cancer patients. The way is to go. The next step is to see if this result can be repeated by human cells in the laboratory, and then use patients to conduct larger-scale experiments. "

Galvanized Garden Edging

Fearue for landscaping, edging lawns, paths or follower beds around the garden.

Durable:Made by robust galvanized weather-resistan steel sheet. It also can be customized in variouscolor of powder coating surface treatment based on customer's requirements.

Fexible usage:It can be adapted to various shapes and uses in a multiple function. Inserted curved or angled. It can be easily bent to paths corners Also can be extended as required with simple connector system.

Easy installation:The edging has a special design interlocking system to connect sections which lead a fast install function.Without any complicate measures, It can be installed with one timber and mallet.

PackingPacking will by pallet/carton/ wooden box,according to different demand.The wooden support is made of log or square wood, and the iron support is a special iron brace foot for the transverse brace. Steel pile retaining plate support is to drive the slotted steel sheet pile with pile driving machinery before the trench and foundation pit excavation.

Galvanized Garden Edging,Galvanised Lawn Edging,Galvanised Steel Edging,Galvanized Steel Lawn Edging

Henan Jinbailai Industrial Co.,Ltd , https://www.jblbbqgrill.com